{
  "retracted": false,
  "timestamp": 1564444800000,
  "updates": [
    {
      "timestamp": 1569924670406,
      "identifier": {
        "doi": "10.1038/s41416-019-0534-2"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41416-019-0506-6"
  },
  "journal": "British Journal of Cancer",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma"
}
